MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,037,000 | +37.6% | 70,061 | +117.8% | 0.11% | +26.7% |
| Q3 2018 | $1,480,000 | -30.1% | 32,166 | -45.0% | 0.09% | -65.3% |
| Q3 2017 | $2,117,000 | +501.4% | 58,500 | +408.7% | 0.26% | +114.0% |
| Q2 2016 | $352,000 | +1073.3% | 11,500 | +1337.5% | 0.12% | +830.8% |
| Q1 2016 | $30,000 | -56.5% | 800 | -50.0% | 0.01% | -72.3% |
| Q4 2015 | $69,000 | +13.1% | 1,600 | -11.1% | 0.05% | -53.9% |
| Q4 2014 | $61,000 | -99.6% | 1,800 | +356.9% | 0.10% | +750.0% |
| Q3 2014 | $15,197,000 | +18661.7% | 394 | -81.1% | 0.01% | -84.6% |
| Q2 2014 | $81,000 | +224.0% | 2,083 | +73.6% | 0.08% | +178.6% |
| Q4 2013 | $25,000 | – | 1,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |